Quantcast
Skin Cells Reprogrammed Into Brain Cells

Skin Cells Reprogrammed Into Brain Cells

Provided by Julia Evangelou Strait, Washington University School of Medicine in St. Louis Scientists have described a way to convert human skin cells directly into a specific type of brain cell affected by Huntington’s disease, an ultimately...

Latest Stem cells Stories

2014-10-31 08:27:01

WASHINGTON, Oct. 31, 2014 /PRNewswire-USNewswire/ -- Consumer Watchdog and the Public Patent Foundation today asked the U.S Supreme Court to overturn a lower court's decision and allow the two public interest groups to seek the cancellation of a patent on human embryonic stem cells held by the Wisconsin Alumni Research Foundation (WARF). In its petition, Consumer Watchdog, which is represented by the Public Patent Foundation, asked the high court to overturn a June ruling from the...

2014-10-31 08:25:10

MENLO PARK, Calif., Oct. 31, 2014 /PRNewswire/ -- Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a leading biotechnology company in the emerging field of regenerative medicine, today announced that it will release third quarter financial and operating results on Monday, November 10, 2014 after the close of the U.S. financial markets. The Company will host a conference call via webcast on Monday, November 10, 2014 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss third quarter...

2014-10-31 08:23:29

NEW YORK, Oct. 31, 2014 /PRNewswire/ -- Though therapies are in their nascent phase, sales of stem cell technologies are expected to show an annual increase of 16.2% over the 2010-2020 period, reaching an expected market value of nearly $1 billion, according to Kalorama Information's report, Stem Cell Therapeutics Markets. This includes revenues from proprietary stem cell therapeutics that have gained or are expected to gain approval from respected regulatory authorities....

2014-10-30 23:17:25

On Thursday, October 30, at 4:10 pm at Rhode Island Hospital’s inaugural “Novel Stem Cells & Vesicles Symposium” in Providence, Dr. James L. Sherley, director of Boston’s Adult Stem Cell Technology Center, LLC, will provide details of the company’s new technology for monitoring human adult tissue stem cells. With its partner company AlphaSTAR Corporation, ASCTC is positioning the new technology, which integrates innovation in human cell culture with computer simulation, to...

2014-10-30 23:12:24

Dr. James A. Manganello, Provia Laboratories Chairman of the Board, has been appointed to the National Stem Cell Ethics Committee (NSCEC) of The Bahamas. As a leading international private equity consultancy, Grace Century’s cutting-edge stem cell biobank project, Provia Laboratories, specializes in high quality biobanking (the collection, transport, processing, and cryogenic storage of biological specimens). Ras Al Khaimah, UAE (PRWEB) October 30, 2014 Grace Century portfolio project,...

2014-10-30 23:05:16

Dr. Roy Schmidt and the staff of the Pain Specialist Center will host a free seminar and question-and-answer session about regenerative medicine on Tuesday, Nov. 11 at 6 p.m. Held at the clinic at 15 Stonebridge Blvd. in Jackson, the hour-long event will allow attendees to ask questions about stem cell therapy and platelet rich plasma therapy in a relaxed atmosphere. JACKSON, Tenn. (PRWEB) October 30, 2014 Dr. Roy Schmidt and the staff of the Pain Specialist Center will host a free...

2014-10-30 12:28:54

NEW YORK, Oct. 30, 2014 /PRNewswire-USNewswire/ -- The New York Blood Center's Milstein National Cord Blood Program (NCBP) is pleased to announce that HEMACORD(®), the first FDA-licensed hematopoietic stem cell product, has been awarded the prestigious "Best Biotechnology Product" Award by Prix Galien USA. The award recognizes "biomedical products that advance the human condition and which were approved by the U.S. Food and Drug Administration (FDA) during the past five years,"...

2014-10-30 08:29:59

WASHINGTON and NEW YORK and LONDON, Oct. 30, 2014 /PRNewswire/ -- As a leading provider of market research, MarketResearch.com announces the distribution of a report by BioInformant Worldwide, LLC, revealing the continued 14.7% annual growth of the induced pluripotent stem cell (iPSC) market. http://photos.prnewswire.com/prnvar/20140801/132627 To learn more about the induced pluripotent stem cell market, visit:...

2014-10-30 04:20:57

AMSTERDAM, October 30, 2014 /PRNewswire/ -- Kiadis Pharma B.V. ("Kiadis Pharma" or "the Company"), a clinical stage biopharmaceutical company developing T-cell immunotherapy treatments for blood cancers, today announces that its lead product ATIR(TM) has been granted Orphan Drug Designation (ODD) by the European Medicines Agency (EMA) for the treatment of acute myeloid leukemia (AML). Kiadis Pharma has previously been granted an ODD for ATIR(TM) by both the EMA and the FDA for...

2014-10-29 23:14:08

Upcoming San Marcos and Carlsbad, California Adult Stem Cell Lectures on Wednesday and Thursday, November 5 and 6, 2014. San Marcos and Carlsbad, California (PRWEB) October 29, 2014 The Irvine Stem Cell Treatment Center announces a series of free public seminars on the use of adult stem cells for various chronic, degenerative and inflammatory conditions. They will be provided by Dr. Thomas A. Gionis, Surgeon-in-Chief. The seminars will be held on Wednesday, November 5, 2014, at 11:30am...


Word of the Day
maffling
  • To stammer.
  • Present participle of maffle, to stammer.
  • A simpleton.
The word 'maffle' may come from a Dutch word meaning 'to move the jaws' or a French word meaning 'having large cheeks'.